Skip to content

Clinical trials

Phase 2 Hepatitis C trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 2 Clear all

262 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20026
20033
20046
200514
200611
200712
200811
200924
201029
201122
201216
201323
201417
201517
201613
20178
20187
20199
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed215
Terminated24
Unknown status12
Withdrawn10
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences46
Bristol-Myers Squibb19
Merck Sharp & Dohme LLC19
National Institute of Allergy and Infectious Diseases (NIAID)13
AbbVie (prior sponsor, Abbott)11
ANRS, Emerging Infectious Diseases8
AbbVie8
Vertex Pharmaceuticals Incorporated7
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)5
BioWest Therapeutics Inc4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C262
Hepatitis C, Chronic65
Hepatitis20
HIV Infections19
Fibrosis14
Liver Diseases13
Liver Cirrhosis8
Hepatitis B6
Virus Diseases6
Bronchiolitis Obliterans Syndrome5

Trials

Showing 51 to 75 of 262. Each trial links to its page on Pharma Observatory.

162 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.